OvaScience Inc (NASDAQ:OVAS) saw unusually-high trading volume on Friday . Approximately 2,501,094 shares traded hands during mid-day trading, an increase of 47% from the previous session’s volume of 1,702,366 shares.The stock last traded at $1.18 and had previously closed at $1.11.

OVAS has been the subject of several research analyst reports. Zacks Investment Research upgraded OvaScience from a “hold” rating to a “buy” rating and set a $1.50 price objective for the company in a report on Wednesday, October 4th. HC Wainwright reissued a “buy” rating and issued a $15.00 target price on shares of OvaScience in a research report on Monday, November 6th.

The company has a market cap of $41.95, a PE ratio of -0.64 and a beta of 3.73.

Large investors have recently made changes to their positions in the company. Zacks Investment Management bought a new position in shares of OvaScience in the 2nd quarter worth approximately $140,000. Susquehanna International Group LLP raised its position in shares of OvaScience by 87.2% in the 2nd quarter. Susquehanna International Group LLP now owns 112,781 shares of the biotechnology company’s stock worth $176,000 after acquiring an additional 52,538 shares in the last quarter. Wells Fargo & Company MN raised its position in shares of OvaScience by 28.8% in the 2nd quarter. Wells Fargo & Company MN now owns 164,283 shares of the biotechnology company’s stock worth $256,000 after acquiring an additional 36,720 shares in the last quarter. Broadfin Capital LLC bought a new position in shares of OvaScience in the 2nd quarter worth approximately $429,000. Finally, Legal & General Group Plc raised its position in shares of OvaScience by 4,654.1% in the 2nd quarter. Legal & General Group Plc now owns 458,822 shares of the biotechnology company’s stock worth $713,000 after acquiring an additional 449,171 shares in the last quarter. 55.06% of the stock is owned by hedge funds and other institutional investors.

ILLEGAL ACTIVITY WARNING: “OvaScience (OVAS) Sees Large Volume Increase” was originally posted by TheOlympiaReport and is the property of of TheOlympiaReport. If you are reading this article on another publication, it was illegally copied and republished in violation of United States & international trademark and copyright law. The legal version of this article can be read at https://theolympiareport.com/2018/01/12/ovascience-ovas-sees-large-volume-increase.html.

OvaScience Company Profile

OvaScience, Inc is a global fertility company. The Company is focused on the discovery, development and commercialization of fertility treatment options for women. The Company’s portfolio of fertility treatment options uses its technology, including methods to identify and isolate Egg precursor (EggPC) cells from a patient’s own ovarian tissue.

Receive News & Ratings for OvaScience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OvaScience and related companies with MarketBeat.com's FREE daily email newsletter.